Transgenomic - 24 Year Stock Price History | PRPO
Historical daily share price chart and data for Transgenomic since 2000 adjusted for splits and dividends. The latest closing stock price for Transgenomic as of April 26, 2024 is 6.03.
- The all-time high Transgenomic stock closing price was 2591999.87 on July 18, 2000.
- The Transgenomic 52-week high stock price is 14.80, which is 145.4% above the current share price.
- The Transgenomic 52-week low stock price is 4.75, which is 21.2% below the current share price.
- The average Transgenomic stock price for the last 52 weeks is 7.36.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Transgenomic Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2024 |
6.3261 |
6.5100 |
6.9079 |
5.2700 |
6.0250 |
-7.31% |
| 2023 |
10.0411 |
12.3811 |
20.0000 |
5.3040 |
6.5000 |
-41.06% |
| 2022 |
22.2048 |
34.2000 |
34.2000 |
9.9420 |
11.0280 |
-65.10% |
| 2021 |
56.0444 |
42.0000 |
105.0000 |
31.6000 |
31.6000 |
-23.67% |
| 2020 |
34.4707 |
39.8000 |
140.0000 |
11.6000 |
41.4000 |
0.98% |
| 2019 |
63.9458 |
48.0000 |
183.0000 |
36.2080 |
41.0000 |
-11.26% |
| 2018 |
147.2715 |
345.0000 |
390.0000 |
45.0000 |
46.2000 |
-87.17% |
| 2017 |
3220.7612 |
2636.9999 |
10079.9995 |
201.0000 |
360.0000 |
-85.93% |
| 2016 |
4289.8748 |
9539.9995 |
9722.6995 |
1424.6999 |
2557.7999 |
-73.44% |
| 2015 |
13868.0636 |
18539.9991 |
35099.9982 |
6758.9997 |
9629.9995 |
-46.77% |
| 2014 |
35849.6339 |
50759.9975 |
58319.9971 |
13679.9993 |
18089.9991 |
-63.59% |
| 2013 |
48359.9976 |
70199.9965 |
77759.9961 |
33479.9983 |
49679.9975 |
-24.59% |
| 2012 |
104457.5948 |
139319.9930 |
145799.9927 |
58319.9971 |
65879.9967 |
-52.71% |
| 2011 |
127011.4222 |
65879.9967 |
191159.9904 |
65879.9967 |
139319.9930 |
95.45% |
| 2010 |
61431.4255 |
73439.9963 |
95039.9952 |
34559.9983 |
71279.9964 |
-4.35% |
| 2009 |
51591.4260 |
41039.9979 |
79919.9960 |
22679.9989 |
74519.9963 |
56.82% |
| 2008 |
62055.1748 |
58319.9971 |
92879.9954 |
26999.9987 |
47519.9976 |
-18.52% |
| 2007 |
70058.0045 |
47519.9976 |
93959.9953 |
47519.9976 |
58319.9971 |
20.00% |
| 2006 |
64997.9250 |
102599.9949 |
109079.9945 |
41039.9979 |
48599.9976 |
-57.55% |
| 2005 |
96149.9952 |
118799.9941 |
133919.9933 |
48599.9976 |
114479.9943 |
-7.83% |
| 2004 |
172602.8485 |
224639.9888 |
348839.9826 |
112319.9944 |
124199.9938 |
-43.07% |
| 2003 |
203249.9898 |
246239.9877 |
448199.9776 |
116639.9942 |
218159.9891 |
-9.42% |
| 2002 |
547122.8298 |
1163159.9418 |
1163159.9418 |
226799.9887 |
240839.9880 |
-79.73% |
| 2001 |
948357.5332 |
971999.9514 |
1328399.9336 |
593999.9703 |
1187999.9406 |
4.76% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.009B |
$0.015B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
